Market Tracker

03/27 5:16pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

0.65
Delayed Data
As of 3:18pm ET
 0.00 / 0.00%
Today’s Change
0.56
Today|||52-Week Range
2.00
-47.15%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close0.65
Today’s open0.63
Day’s range0.61 - 0.65
Volume31,027
Average volume (3 months)135,291
Market cap$25.1M
Dividend yield--
Data as of 3:18pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book0.54

Competitors

 Today’s
change
Today’s
% change
IMNPImmune Pharmaceutica...-0.00-0.71%
ABIOARCA Biopharma Inc-0.07-2.83%
VICLVical Inc+0.02+0.93%
OGENOragenics Inc-0.03-6.25%
Data as of 3:59pm ET, 03/27/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts